Published in Infect Immun on October 01, 2004
Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar J (2008) 1.22
Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria. Mol Cell Proteomics (2014) 0.81
Coexpression of PPE 34.9 Antigen of Mycobacterium avium subsp. Paratuberculosis with Murine Interferon Gamma in HeLa Cell Line and Study of Their Immunogenicity in Murine Model. Biotechnol Res Int (2011) 0.75
The pathogenic basis of malaria. Nature (2002) 10.44
Chemokines: immunology's high impact factors. Nat Immunol (2001) 3.36
Immunisation with recombinant AMA-1 protects mice against infection with Plasmodium chabaudi. Vaccine (1998) 3.16
Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1alpha promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem Biophys Res Commun (1998) 2.16
Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med (1996) 2.15
Immune effector mechanisms in malaria. Curr Opin Immunol (1999) 1.86
Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol (2002) 1.61
Towards a blood-stage vaccine for malaria: are we following all the leads? Nat Rev Immunol (2001) 1.60
A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol (1998) 1.54
Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection. J Immunol (1996) 1.49
Polycistronic viral vectors. Curr Gene Ther (2002) 1.47
Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res (2001) 1.43
Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol (1997) 1.36
Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol (1999) 1.35
Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro. Infect Immun (1998) 1.20
The resolution of acute malaria in a definitive model of B cell deficiency, the JHD mouse. J Immunol (1994) 1.11
DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. Int J Parasitol (2001) 1.10
Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun (1998) 1.09
Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii. Infect Immun (2002) 1.08
A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol (2002) 1.08
Identification of the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum. Infect Immun (1999) 1.01
Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1. Vaccine (2003) 0.98
Antibody recognition of rodent malaria parasite antigens exposed at the infected erythrocyte surface: specificity of immunity generated in hyperimmune mice. Infect Immun (2001) 0.87
Expression library immunization protects mice against a challenge with virulent rodent malaria. Vaccine (2000) 0.87
Absence of antigenic competition in Aotus monkeys immunized with Plasmodium falciparum DNA vaccines delivered as a mixture. Vaccine (2002) 0.86
The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol. Vaccine (2003) 0.84
Enhanced cellular immunity to hepatitis C virus nonstructural proteins by codelivery of granulocyte macrophage-colony stimulating factor gene in intramuscular DNA immunization. Vaccine (1999) 0.83
Vaccines against asexual stage malaria parasites. Chem Immunol (2002) 0.83
Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization? Dev Biol (Basel) (2000) 0.83
Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors. Infect Immun (2003) 0.81
Nucleic acid vaccines against malaria. Chem Immunol (2002) 0.81
The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma. Vaccine (2002) 0.77
Isolation and characterization of infective and non-infective clones of Leishmania tropica. Mol Biochem Parasitol (1983) 1.76
Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci U S A (1988) 1.63
DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun (2000) 1.44
CD4+ T cells contain Mycobacterium tuberculosis infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A. Eur J Immunol (2000) 1.37
The kinetoplast DNA of the hemoflagellate protozoa. Am J Trop Med Hyg (1980) 1.26
Leishmania major and L. donovani: a method for rapid purification of amastigotes. Exp Parasitol (1990) 1.23
Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages. J Immunol (1986) 1.13
Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture. Mol Biochem Parasitol (1991) 1.11
Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep. J Immunol (1990) 1.08
An antigenically distinct lipophosphoglycan on amastigotes of Leishmania major. Mol Biochem Parasitol (1991) 1.05
Variants of a Leishmania surface antigen derived from a multigenic family. J Biol Chem (1991) 1.05
Natural regulatory (CD4+CD25+FOXP+) T cells control the production of pro-inflammatory cytokines during Plasmodium chabaudi adami infection and do not contribute to immune evasion. Int J Parasitol (2007) 1.04
The molecular karyotype of Leishmania major and mapping of alpha and beta tubulin gene families to multiple unlinked chromosomal loci. Nucleic Acids Res (1985) 1.04
Identification of species, strains and clones of Leishmania by characterization of kinetoplast DNA minicircles. Mol Biochem Parasitol (1984) 1.03
The sensitivity and specificity of two methods for detecting Fasciola infections in cattle. Vet Parasitol (1999) 1.02
A family of heat shock protein 70-related genes are expressed in the promastigotes of Leishmania major. Nucleic Acids Res (1989) 1.02
Vaccination against cutaneous leishmaniasis in mice using nonpathogenic cloned promastigotes of Leishmania major and importance of route of injection. Aust J Exp Biol Med Sci (1984) 1.02
Examination of variables in the vaccination of mice against cutaneous leishmaniasis using living avirulent cloned lines and killed promastigotes of Leishmania major. Int J Parasitol (1985) 1.01
Biogenesis of mitochondria. The effects of altered membrane lipid composition on cation transport by mitochondria of Saccharomyces cerevisiae. Biochem J (1973) 1.01
Fasciola hepatica: characterization and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke. Exp Parasitol (1998) 1.00
Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole. Vet Parasitol (2013) 0.96
Genomic organization, chromosomal location and transcription of dispersed and repeated tubulin genes in Leishmania major. Mol Biochem Parasitol (1987) 0.95
Evaluation of antigens of Fasciola gigantica as vaccines against tropical fasciolosis in cattle. Int J Parasitol (1997) 0.95
Characterization of integral membrane proteins of Leishmania major by Triton X-114 fractionation and analysis of vaccination effects in mice. Infect Immun (1989) 0.94
The developmentally regulated P100/11E gene of Leishmania major shows homology to a superfamily of reductase genes. J Biol Chem (1989) 0.93
Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine (1996) 0.92
Opsonization of Toxoplasma gondii tachyzoites with nonspecific immunoglobulins promotes their phagocytosis by macrophages and inhibits their proliferation in nonphagocytic cells in tissue culture. Parasite Immunol (1999) 0.92
The secreted cathepsin L-like proteinases of the trematode, Fasciola hepatica, contain 3-hydroxyproline residues. Biochem J (1994) 0.92
Mutations of the mitochondrial DNA of Saccharomyces cerevisiae which affect the interaction between mitochondrial ribosomes and the inner mitochondrial membrane. Mol Gen Genet (1978) 0.92
Primary sequence heterogeneity and tissue expression of glutathione S-transferases of Fasciola hepatica. Exp Parasitol (1992) 0.91
A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica. Protein Sci (2000) 0.91
The PSA-2 glycoprotein complex of Leishmania major is a glycosylphosphatidylinositol-linked promastigote surface antigen. J Immunol (1989) 0.91
Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype-phenotype correlations. Hum Mutat (1998) 0.90
Discovery and validation of serum biomarkers expressed over the first twelve weeks of Fasciola hepatica infection in sheep. Int J Parasitol (2007) 0.90
Identification of maxicircle DNA sequences in Leishmania Tarentolae that are homologous to sequences of specific yeast mitochondrial structural genes. Mol Biochem Parasitol (1982) 0.90
Antibody-dependent cell-mediated cytotoxicity to newly excysted juvenile Fasciola hepatica in vitro is mediated by reactive nitrogen intermediates. Parasite Immunol (2001) 0.90
Vaccination with a Plasmodium chabaudi adami multivalent DNA vaccine cross-protects A/J mice against challenge with P. c. adami DK and virulent Plasmodium chabaudi chabaudi AS parasites. Int J Parasitol (2007) 0.90
Atypical (mild) forms of dihydropteridine reductase deficiency: neurochemical evaluation and mutation detection. Pediatr Res (1992) 0.89
Biochemical analysis of recombinant glutathione S-transferase of Fasciola hepatica. Mol Biochem Parasitol (1995) 0.88
Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of antibody epitopes on a three-dimensional model of the antigen. J Immunol (1994) 0.88
Cloning of developmentally regulated genes from Leishmania major and expression following heat induction. J Biol Chem (1989) 0.88
Improving animal and human health through understanding liver fluke immunology. Parasite Immunol (2010) 0.87
Two new mutations in the dihydropteridine reductase gene in patients with tetrahydrobiopterin deficiency. J Med Genet (1993) 0.87
Expression library immunization protects mice against a challenge with virulent rodent malaria. Vaccine (2000) 0.87
Characterization of a second nuclear gene, AEP1, required for expression of the mitochondrial OLI1 gene in Saccharomyces cerevisiae. Curr Genet (1993) 0.86
Leishmania major: expression and gene structure of the glycoprotein 63 molecule in virulent and avirulent clones and strains. Exp Parasitol (1990) 0.86
Juvenile Fasciola hepatica are resistant to killing in vitro by free radicals compared with larvae of Schistosoma mansoni. Parasite Immunol (2000) 0.86
Fasciola hepatica: stage-specific expression of novel gene sequences as identified by differential display. Exp Parasitol (1998) 0.85
Characterisation of humoral immune responses in dogs vaccinated with irradiated Ancylostoma caninum. Vet Immunol Immunopathol (2003) 0.85
Humoral responses in mice following vaccination with DNA encoding glutathione S-transferase of Fasciola hepatica: effects of mode of vaccination and the cellular compartment of antigen expression. Parasite Immunol (1999) 0.85
Crystallization, structural determination and analysis of a novel parasite vaccine candidate: Fasciola hepatica glutathione S-transferase. J Mol Biol (1997) 0.84
Sequence of a cDNA for the ND1 gene from Leishmania major: potential uridine addition in the polyadenosine tail. Mol Biochem Parasitol (1989) 0.84
A novel member of the NK-lysin protein family is developmentally regulated and secreted by Fasciola hepatica. Mol Biochem Parasitol (2000) 0.84
The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol. Vaccine (2003) 0.84
Inhibitory effects of chloramphenicol isomers and other antibiotics on protein synthesis and respiration in procyclic Trypanosoma brucei brucei. Mol Biochem Parasitol (1981) 0.84
Characterisation of a novel Kunitz-type molecule from the trematode Fasciola hepatica. Mol Biochem Parasitol (1995) 0.82
Fasciola hepatica: irradiation-induced alterations in carbohydrate and cathepsin-B protease expression in newly excysted juvenile liver fluke. Exp Parasitol (1996) 0.82
Structure function studies of the phenylalanine hydroxylase active site and a summary of structural features. Adv Exp Med Biol (1993) 0.82
Molecular karyotype of five species of Leishmania and analysis of gene locations and chromosomal rearrangements. Mol Biochem Parasitol (1987) 0.82
Developmental expression of a Fasciola hepatica sequence homologous to ABC transporters. Int J Parasitol (1998) 0.81
Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors. Infect Immun (2003) 0.81
Molecular characterization of cDNA sequences encoding glutathione S-transferases of Fasciola hepatica. Exp Parasitol (1992) 0.81
Acquisition of resistance against Fasciola gigantica by Indonesian thin tail sheep. Vet Parasitol (1997) 0.81
Host responses during experimental infection with Fasciola gigantica and Fasciola hepatica in Merino sheep II. Development of a predictive index for Fasciola gigantica worm burden. Vet Parasitol (2008) 0.81
Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice. Exp Parasitol (2001) 0.80
Identification of two allelic forms of ovine CD4 exhibiting a Ser183/Pro183 polymorphism in the coding sequence of domain 3. Vet Immunol Immunopathol (2006) 0.80
Resistance of Indonesian thin tail sheep against Fasciola gigantica and F. hepatica. Vet Parasitol (1997) 0.80
Characterization of isolates and clones of Leishmania by analysis of kinetoplast DNA. J Cell Biochem (1984) 0.80
Resistance and susceptibility of mice to Leishmania major: a view from Melbourne. Ann Inst Pasteur Immunol (1988) 0.80
Construction and immunogenicity of Salmonella vaccine vector expressing HIV-1 antigen and MCP3. Acta Microbiol Immunol Hung (2009) 0.80
Biogenesis of mitochondria 48: mikamycin resistance in Saccharomyces cerevisiae--a mitochondrial mutation conferring resistance to an antimycin A-like contaminant in mikamycin. Mol Gen Genet (1977) 0.80
Biogenesis of mitochondria 51: biochemical characterization of a mitochondrial mutation in Saccharomyces cerevisiae affecting the mitochondrial ribosome by conferring resistance to aminoglycoside antibiotics. Mol Gen Genet (1979) 0.79
Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine. Infect Immun (2005) 0.79
Immune responses in Indonesian thin tail and Merino sheep during a primary infection with Fasciola gigantica: lack of a specific IgG2 antibody response is associated with increased resistance to infection in Indonesian sheep. Int J Parasitol (1999) 0.79
Fasciola hepatica: localisation of glutathione S-transferase isoenzymes in adult and juvenile liver fluke. Exp Parasitol (1995) 0.79
Isolation, cloning, and expression of fatty-acid binding proteins from Fasciola gigantica. Exp Parasitol (1997) 0.78
Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection. Vet Parasitol (2006) 0.78
Immunological approaches for the control of fasciolosis. Int J Parasitol (1997) 0.77
MIF-1 can accelerate neuromotor, EEG and behavioral development in mice. Peptides (1990) 0.77
Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae. Int J Parasitol (1995) 0.75
Molecular analysis of dihydropteridine reductase deficiency: identification of two novel mutations in Japanese patients. Hum Genet (1997) 0.75
Altered mitochondrial ribosomes in a cold-sensitive mutant of Saccharomyces cerevisiae. Mol Biol Rep (1978) 0.75
Molecular typing of Salmonella enterica serovar Sofia in Australia by pulsed-field gel electrophoresis and repetitive element PCR typing. J Appl Microbiol (2009) 0.75
Molecular characterization of cDNA sequences encoding glutathione S-transferases of Fasciola hepatica. Exp Parasitol (1993) 0.75
Identification of 3-hydroxyproline residues in several proteins of Fasciola hepatica. Exp Parasitol (1996) 0.75
Inability to reproduce protection against Teladorsagia circumcincta in sheep with a purified stage-specific 31 kDa antigen complex. Vaccine (1995) 0.75
Nucleotide sequence of a cDNA encoding the lipoate acetyl transferase (E2) of human heart pyruvate dehydrogenase complex differs from that of human placenta. Biochem Int (1990) 0.75
Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection. Parasite Immunol (2015) 0.75